Effect of Auriculotherapy in treatment of Covid 19

Not Applicable

Recruiting

• Conditions: covid19.; COVID 19; P07.14

• Registration Number: IRCT20180608040007N2
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patients hospitalized for infectious parts suspected of having covid 19
Age from 10 to 70 years
Having a healthy double ear (for uricotherapy)
Participants self-reported for: no depression, no psychotropic medications, no pacemakers, no platinum or no metal objects in the body

Exclusion Criteria

Swelling, infection and sores in both ears in the intervention group
Use of psychotropic drugs, antidepressants
Occurrence of stressful events such as the death of loved ones, unfortunate events
The desire to end treatment
Worsening of the patient's condition and the need for an ICU

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improving the clinical course. Timepoint: Daily control of clinical symptoms up to 7 days after uricycliotherapy. Method of measurement: Arterial oxygen with pulse oximeter, anxiety with questionnaire, sleep quality with questionnaire,.